Lyons v. Scitex Corp.

987 F. Supp. 271, 1997 U.S. Dist. LEXIS 19520, 1997 WL 759463
CourtDistrict Court, S.D. New York
DecidedDecember 9, 1997
Docket95 CIV. 10594(HB)
StatusPublished
Cited by2 cases

This text of 987 F. Supp. 271 (Lyons v. Scitex Corp.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lyons v. Scitex Corp., 987 F. Supp. 271, 1997 U.S. Dist. LEXIS 19520, 1997 WL 759463 (S.D.N.Y. 1997).

Opinion

OPINION AND ORDER

BAER, District Judge.

Plaintiff brings this putative class action based on alleged violations of the Securities Exchange Act of 1934 on behalf of himself and all others who purchased Scitex stock from May 12, 1994 through November 9, 1995 (the “Class Period”). Plaintiff and defendants have reached a settlement and seek this Court’s approval pursuant to Fed. R.Civ.P. 23(e). Plaintiffs counsel also makes an application for attorney’s fees. For the reasons discussed below, the settlement is approved and the application for attorney’s fees is granted in part.

BACKGROUND

Plaintiff alleges that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10 — b(5) promulgated thereunder by failing to disclose to the public expected losses attributable to the Company’s third-party financing arrangements. Specifically, plaintiff alleges that toward the end of 1993, defendant Igal Kohavi, a Scitex director, presented to the Board an analysis indicating suspected financial difficulties; that nonetheless the Company and the defendants continued to issue optimistic press releases; that the Company made a partial disclosure of the problems on July 19, 1995; and that the Company did not fully disclose the extent of its financial difficulty until November 9, 1995, when it reported a third quarter loss of $26.4 million.

Defendants moved to dismiss the complaint and for judgment on the pleadings. By Memorandum and Order dated August 21, 1996, I denied the motions with leave to renew following discovery. Specifically, I found that the complaint was sustained “by only the barest of margins,” ordered defendants to produce relevant documents and permitted the deposition of Mr. Kohavi and one additional defendant. Following the production of documents and the depositions, the parties reached a settlement and are here now to seek Court approval pursuant to Fed. R.Civ.P. 23(e).

The proposed settlement would establish a fund of $2,875 million, to be funded by the defendants. From this fund, plaintiffs counsel’s expenses and fees would be paid, as would expenses incurred in administering the settlement. The remainder would be distributed to class members who file valid proofs of claim. The proposed methodology for calculating each class member’s loss is as follows. For class members who sold their shares during the class period, loss is calculated as the difference between the net purchase price of the shares and the net sales price (but no lower than the lowest price at which shares traded in November 1995). See Stipulation ¶ 8.6(a). 1 For class members who *273 did not sell their shares during the Class Period, loss is calculated as the purchase price minus $16. That is, those class members who purchased Scitex shares during the class period for less than $16 would receive no recovery for those shares. The theory behind this loss calculation methodology is that $16 represents the correct “uninflated” value of Scitex shares during the class period. See PL Mem. at 81. The $16 figure was chosen because it reflects the approximate value of Scitex shares at the close of the class period, i.e. after the loss became public.

On May 14, 1997 I entered an order (the “hearing order”) scheduling a hearing to determine the fairness, reasonableness and adequacy of the proposed settlement. The hearing order preliminarily approved the settlement as fair, without prejudice to the Court’s final decision on this motion. The order also conditionally certified the class for purposes of settlement, “in accordance with Article II of the Stipulation” entered into by the parties. Article II of the Stipulation, in turn, provides that “Plaintiff will submit any documentation that may be necessary to support the entry of an order of Class certification.”

The settlement hearing was held on August 21, 1997. In addition to counsel for plaintiff and defendants, two objectors were present: Solomon Borg, on behalf of various family members, and Robert Weinberg, on behalf of himself and his wife, Patricia. The objectors objected to the (i) the definition of the class period; (ii) the formula for determining loss pursuant to the proposed 'settlement; (iii) the adequacy of notice given to the class as to the details of the proposed settlement and (iv) the excessiveness of plaintiffs counsel’s fee request. After hearing from counsel and the objectors, the Court expressed concern with the fact that plaintiff had failed to address, the question of class certification, and particularly the Supreme Court’s recent decision in Amchem Products, Inc. v. Windsor, — U.S. -, 117 S.Ct. 2231, 138 L.Ed.2d 689 (1997). The Court also expressed concern with the lack of documentation supporting plaintiffs counsel’s attorney’s fee request; the lack of information regarding plaintiffs damage analysis; and the lack of information regarding the number of shares traded during the Class Period and what the proposed settlement would actually mean for class members in terms of return on each dollar of alleged loss — i.e., what share of each class member’s loss they would recover pursuant to the parties’ proposed loss calculation methodology.

As a consequence of these concerns, the plaintiff filed an' affidavit and an additional memorandum of law addressing the appropriateness of class certification and an affidavit by plaintiffs counsel providing more detail as to the damage analysis, loss calculation and attorney’s fees application. Plaintiffs counsel also provided, after repeated requests, information regarding the number of claimants and their total calculated losses. 2 Defendants and objectors also filed supplemental papers, with objectors picking up on the Court’s concerns and objecting to plaintiff’s standing to represent the class.

DISCUSSION

Although this case is not governed by the recently-enacted Private Securities Litigation Reform Act (“PSLRA” or the “Act”), 3 the Court’s consideration of the settlement agreement and application for attorney’s fees is nonetheless informed by the public policy principles underlying certain of the Act’s pro *274 visions. Three provisions are of particular importance: the Act’s requirements (i) that the “most adequate plaintiff’ be appointed as lead plaintiff, (ii) that certain notice be given to class members regarding any proposed settlement and (iii) that attorney’s fees requests be considered in light of the total benefit to plaintiffs, as opposed to the total settlement fund. I address each of these provisions in the discussion below.

I. Class Certification

The first hurdle that plaintiff must overcome is the issue of class certification. Pursuant to Rule 23, class actions can be maintained only if:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Oxford Health Plans, Inc. Securities Litigation
244 F. Supp. 2d 247 (S.D. New York, 2003)
Polar International Brokerage Corp. v. Reeve
187 F.R.D. 108 (S.D. New York, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
987 F. Supp. 271, 1997 U.S. Dist. LEXIS 19520, 1997 WL 759463, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lyons-v-scitex-corp-nysd-1997.